Cargando…
Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies
Human immunodeficiency virus type 1 (HIV-1) infection causes acquired immune deficiency syndrome (AIDS), a global epidemic for more than three decades. HIV-1 replication is primarily controlled through antiretroviral therapy (ART) but this treatment does not cure HIV-1 infection. Furthermore, there...
Autores principales: | Zhang, Zhiqing, Li, Shaowei, Gu, Ying, Xia, Ningshao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133900/ https://www.ncbi.nlm.nih.gov/pubmed/27869733 http://dx.doi.org/10.3390/ijms17111901 |
Ejemplares similares
-
Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody
por: Wang, Daning, et al.
Publicado: (2015) -
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
por: Landais, Elise, et al.
Publicado: (2018) -
Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent
por: Noailly, Blandine, et al.
Publicado: (2022) -
The expanding array of HIV broadly neutralizing antibodies
por: McCoy, Laura E.
Publicado: (2018) -
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
por: Dufloo, Jérémy, et al.
Publicado: (2018)